ANIMATION

Idiopathic Pulmonary Fibrosis and the Effects of Treatment

Share this animation:

About 50,000 people in the United States are diagnosed with IPF each year. After diagnosis, the estimated survival is only 3 years. Patients with IPF deteriorate to the extent that most die of respiratory failure; essentially their lungs can’t get enough oxygen into their blood.

The animation, developed in partnership with Wedgewood Communications, shows the mechanism of disease for IPF and the mechanism of action for the recently-approved agent OFEV (nintedanib) from Boehringer Ingelheim.

The 6.5-minute animation shows in great detail how the lungs work to get oxygen into the blood, how the lung tissue is repaired when damage occurs, and how this repair process goes awry in IPF.

Share It:
Contact XVIVO

Client


Idiopathic Pulmonary Fibrosis and the Effects of Treatment

XVIVO was asked to create an extremely complex but biochemically and biologically accurate animation that depicted the role of neuropeptides in brain plasticity. The final product was astounding — far beyond our expectations. This animation is now being used to educate breast cancer survivors on how cognitive processes are restored after chemotherapy. I would highly recommend XVIVO to others seeking similar products.

Lyn Freeman, Ph.D., CEO, Mind Matters Research, LLC
Share this animation: